Presentation NY Valves 2025 Late Clinical Outcomes After TAVR: Impact of Frailty and Social Vulnerability in a “Real World” Administrative Claims Database Presenter: Gregory P. Fontana June 26, 2025
Presentation NY Valves 2025 Management of HALT After TAVR: Anticoagulation, Which Agent, How Long Presenter: George D. Dangas June 26, 2025
Presentation NY Valves 2025 Long-Term Outcomes After TAVR With a Self-Expanding Prosthesis Presenter: Won-Keun Kim June 26, 2025
Presentation NY Valves 2025 Transcarotid Access for TAVR Using a Balloon Expandable Valve: Contemporary Results from a Real-World Registry Presenter: Keith B. Allen June 26, 2025
Presentation NY Valves 2025 Stroke and Cerebral Embolic Protection Devices in Contemporary TAVR Practice Presenter: Alexandra J. Lansky June 26, 2025
Presentation NY Valves 2025 What Is the Evidence for Clinical Surveillance in Severe Aortic Stenosis? Presenter: Sreekanth Vemulapalli June 26, 2025
Presentation NY Valves 2025 Incidence and Clinical Implications of Conduction Disturbances After TAVR and Post Procedural Management Presenter: Tamim M. Nazif June 26, 2025
Presentation NY Valves 2025 Echo Assessment Remains the Gold Standard Presenter: Leo Marcoff June 26, 2025
Presentation NY Valves 2025 Not if the Invasive Gradients Look Fine Presenter: Brian K. Whisenant June 26, 2025
Presentation NY Valves 2025 Paravalular Leak After TAVR: When to Treat and Options for Closure Presenter: Mackram F. Eleid June 26, 2025
Presentation NY Valves 2025 A Femoral Complication Where Alternative Access Should Have Been Considered Presenter: Rajiv Tayal June 26, 2025
Presentation NY Valves 2025 When the PCI Performed Prior to TAVR Goes South, Maybe I Should Have Waited Until After the TAVR . . . Presenter: Mahesh V. Madhavan June 26, 2025
Presentation NY Valves 2025 Bioprosthetic Valve Remodelling: Optimizing Hemodynamics During TAVR in SAVR Presenter: Fabio Sandoli de Brito June 26, 2025
News Conference News NY Valves 2025 Alerts to Physicians Close Gaps in AS Management Between Women, Men Todd Neale June 25, 2025
Presentation NY Valves 2025 Featured Research: A Prospective, Single-Arm, Multicenter Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During TAVR Presenter: Robert Gooley June 25, 2025
Presentation NY Valves 2025 Updates from the Sentinel Clinical Trial Program: PROTECTED TAVR and BHF PROTECT-TAVI Meta-Analysis Presenter: Samir R. Kapadia June 25, 2025
Presentation NY Valves 2025 Outcomes from the Optimize PRO Evolut FX System Addendum Study: 30-Day and 1-Year Results Presenter: Hemal Gada June 25, 2025
Presentation NY Valves 2025 National Trends in Aortic Valve Replacement in Patients 65 Years and Younger Presenter: Vikrant Jagadeesan June 25, 2025
Presentation NY Valves 2025 Death on Waiting List for Transcatheter Aortic Valve Implantation: Current Incidence, Clinical Characteristics and Predictive Factors Presenter: Hugo Poinsignon June 25, 2025
Presentation NY Valves 2025 Age Considerations for Aortic Progression with BAV: When Is TAVR Still Acceptable? Presenter: Melissa Levack June 25, 2025